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Testicular adrenal rest tumors in a patient with 
untreated congenital adrenal hyperplasia
Testicular adrenal rest tumors (TARTs) are considered to be formed 
from aberrant adrenal tissue that has become hyperplastic because of 
elevated adrenocorticotropic hormone (ACTH) in male patients with 
congenital adrenal hyperplasia (CAH). A 6-year-old boy presented 
with testicular enlargement and pubic hair. He was diagnosed with 
CAH complicated by precocious puberty. However, he was not 
followed-up. At the age of 17, he visited the outpatient clinic because 
of testicular enlargement and short stature. His right and left testicles 
were 10×6 cm and 7.5×4.5 cm, respectively. His height was 155.1 
cm (standard deviation score [SDS], -2.90). The diagnosis of CAH due 
to 21 hydroxylase deficiency was confirmed by mutation analysis 
of CYP21A2. Histological examination of the testes showed large, 
polygonal, eosinophilic cells with round nuclei and prominent nucleoli, 
which were suggestive of TARTs. He was treated with dexamethasone 
for 3 weeks and tumors regressed. Subsequently, dexamethasone 
was replaced by prednisolone and 9α-fludrocortisone; thereafter, the 
reduced testis size has been maintained.
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and the method of tumor detection
3). TARTs are thought to arise 
from aberrant adrenal cells that migrate to the scrotum during the 
descent of the testes or from pluripotent stem cells in the testes
4). 
The growth of these cells in patients with CAH may be caused by 
the chronically elevated levels of ACTH or other, as yet unknown, 
growth promoting factors
5). In patients with CAH, poor compliance 
with treatment increases plasma ACTH levels, accelerating the 
development of TART. Although TARTs are usually benign, they 
may obstruct the seminiferous tubule, leading to possible gonadal 
dysfunction
5). Intensive glucocorticoid therapy, which suppresses 
ACTH secretion, leads to regression of the tumors. If glucocorticoid 
Introduction
Congenital adrenal hyperplasia (CAH) is an autosomal recessively 
inherited disorder of adrenal steroid synthesis, in which glucocorticoid 
and mineralocorticoid deficiencies lead to a compensatory increase 
in adrenocorticotropic hormone (ACTH) secretion, which in 
turn causes adrenocortical hyperplasia and overproduction of 
intermediate metabolites and adrenal androgens
1). Testicular adrenal 
rest tumors (TARTs) are important complications of CAH, resulting 
in infertility, and were first described in 1940
2). TARTs have been 
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treatment is ineffective, however, surgical intervention should be 
considered. We describe here a patient with untreated CAH who 
presented with huge TARTs, which regressed with dexamethasone 
therapy.
Case report
A 2-month old boy was admitted to our primary clinic because of 
poor weight gain, hyponatremia, and hyperkalemia. Initially, he was 
thought to have electrolyte abnormalities caused by dehydration and 
discharged without an exact diagnosis. When he was 6 years old, he 
manifested voice change, acne, testicular enlargement, and premature 
pubarche. His height and weight were 124 cm (2.31 SDS) and 27 
kg (2.63 SDS), respectively. The volume of each testis was 7 mL, 
the stretched penile length was 7 cm, and his bone age was 13 years 
by Greulich and Pyle’s method, which was remarkably advanced 
for his chronological age. His serum 17-hydroxypregnenolone (17-
OHP) and testosterone levels were elevated to 480 ng/mL (normal 
range: 0.32-3 ng/mL) and 2.0 ng/mL (normal range: 0.03‒0.1 
ng/mL), respectively. He was diagnosed with precocious puberty 
caused by CAH. He was treated with hydrocortisone (15 mg/m
2/
day) and 9α -fludrocortisone (0.1 mg/day). However, he did not take 
medicine after 11 months of treatment. At age 17 years, he visited 
our outpatient clinic because of bilateral testicular enlargement and 
short stature. He was scheduled to be treated by surgical resection 
of testicular tumors because testicular biopsy demonstrated large, 
polygonal, and eosinophilic cells with round nuclei and prominent 
nucleoli, which are consistent findings with Leydig cell tumors 
(Fig. 2). His height and weight were 155.1 cm (-2.90 SDS) and 68 
kg (0.49 SDS), respectively, and body mass index (BMI) was 30.2 
(>97th percentile). He was normotensive (110/70 mmHg). His right 
and left testicles measured 10×6 cm, 7.5×4.5 cm, respectively (Fig. 
1), with both being of firm consistency. His pubic hair Tanner stage 
was grade V. Gynecomastia and skin hyperpigmentation were noted. 
Radiography of left hand and wrist showed a closed epiphyseal plate. 
His serum 17-OHP concentration was 506.20 ng/mL (normal range: 
0.32‒3 ng/mL), ACTH level was 187.6 pg/mL (normal range: 2‒49 
pg/mL), plasma renin activity was 20.0 ng/mL/h (normal range: 
0.4‒8.8 ng/mL/h), and dehydroepiandrosterone sulfate (DHEA-S) 
level was 270.6 μg/dL (normal range: 30‒555 μg/dL). He had an 
androstenedione level of 18.0 ng/mL (normal range: 0.57‒1.5 ng/
mL), a luteinizing hormone (LH) concentration of 0.23 mIU/mL 
(normal range: 1.54-7.0 mIU/mL), a follicle-stimulating hormone 
(FSH) level of 1.6 mIU/mL (normal range: 1.54‒7.0 mIU/mL) and 
a testosterone level of 6.13 ng/mL (normal range: 3.5‒9.7 ng/mL). 
His serum sodium and potassium concentrations were 141 mmol/L 
and 4.1 mmol/L, respectively, and serum α -fetoprotein and β -hCG 
levels were 1.4 ng/mL (normal range <20 ng/mL) and 1.0 mIU/mL 
(normal range <5 mIU/mL), respectively. Abdominal computerized 
tomography revealed a 1.5 cm-sized adrenal adenoma on the left side 
and focal adrenal hyperplasia on the right side. Mutation analysis of 
CYP21A2 revealed a compound heterozygote, c.293-13A>G and 
c.1066C>T (p.R356W). To reduce the size of his tumors and to 
Fig. 1. Testicular examination before and after dexamethasone treatment. (A) Before treatment. 
Both testes were enlarged, with the right testis measuring 10×6 cm and the left testis measuring 
7.5×4.5 cm. (B) After 3 weeks of dexamethasone therapy, the volume of each testis was 25 mL. 
Fig 2. Histopathological examination of a testicular biopsy sample. Large 
polygonal cells with abundant eosinophilic cytoplasm and separated 
by fibrous tissue strands were observed. No Reinke crystalloids were 
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improve his hormonal profile, he was prescribed ACTH suppressive 
therapy with dexamethasone (0.25 mg tid). After 3 weeks, the tumors 
markedly regressed. The volume of each testis estimated using a 
Prader orchidometer was 25 mL (Fig. 1). His serum 17-OHP and 
ACTH concentrations had decreased to 1.0 ng/mL and 9.4 pg/mL, 
respectively, and serum testosterone concentration was reduced to 
0.05 ng/mL (normal range: 3.5‒9.7 ng/mL). He was switched from 
dexamethasone to prednisolone (5 mg twice a day) for maintenance, 
which had no effect on the volume of his testes. Following the switch, 
17-OHP concentration was 19.8 ng/mL, ACTH concentration 
was 45.3 pg/mL, plasma renin activity was 20.0 ng/mL/h, and 
testosterone level was 3.0 ng/mL.
Discussion
TARTs can be the first manifestation of CAH and have been 
reported in 18% of undiagnosed CAH patients
2). TARTs usually 
develop in untreated or inadequately treated patients with CAH 
because of chronically elevated ACTH levels. In addition, increased 
levels of LH during the pubertal period has been found to stimulate 
tumor growth by binding of LH to receptors located in tumor tissues. 
Therefore, TARTs are usually detected in adolescence and young 
adulthood, even in adequately treated patients. 
TARTs are usually nodular, firm, well delineated, and separated 
by fibrous bands. Because of their histopathologic resemblance 
on microscopy, it is difficult to differentiate TARTs from Leydig 
cell tumors
6). Both tumors contain polygonal cells with abundant 
eosinophilic or granular cytoplasm in cord-like arrangements 
separated by dense fibrotic tissue
4). TARTs, however, never contain 
the cytoplasmic rod-like crystalloids termed Reinke crystals, a 
pathognomonic finding of Leydig cell tumors found in 20‒40% 
of patients with the latter condition
7). Several clinical characteristics 
can be used to differentiate TARTs from Leydig cell tumors. For 
example, Leydig cell tumors can appear at any age, and only 3% are 
bilateral
8). In contrast, TARTs are more common during adolescence 
and young adulthood, and are usually bilateral
9). Thus, bilateral 
testicular masses in adolescents should be suspected of having TARTs 
with CAH although the histologic findings are consistent with 
Leydig cell tumors. TARTs are benign and reversible without surgical 
intervention if the tumors are found before stage IV by classification 
proposed by Claahsen-van der Grinten HL et al.
3). No cases of 
metastatic TARTs have been reported and tumors shrink after high-
dose glucocorticoid therapy
2). In our patient, TARTs could not be 
clearly differentiated from Leydig cell tumors histopathologically, 
but the marked reduction in testicular size following high-dose 
glucocorticoid therapy suggested that the tumors were TARTs, 
not Leydig cell tumors. Although TARTs have no malignant 
features, they can cause severe testicular damage by compressing the 
seminiferous tubules. Chronic obstruction of the tubules has been 
found to cause peritubular fibrosis and tubular hyalinization, leading 
to irreversible testicular damage
10). In addition to their mechanical 
effects, adrenal androgens produced by such tumors may be toxic 
to Leydig cells and germ cells
11). Therefore, early recognition and 
treatment is required for better prognosis. Because TARTs are 
located adjacent to the mediastinum testis, only tumors of >2 cm are 
detectable by palpation. To find small-sized tumors, ultrasonography 
should be performed in addition to regular digital palpation. 
Ultrasonography has been found to be as sensitive as magnetic 
resonance imaging in detecting small TARTs
12). 
Several treatment modalities have been described that reduce 
tumor size and improve gonadal function. Because these tumors 
result from elevated ACTH concentration, intensive glucocorticoid 
therapy, which suppresses ACTH secretion and leads to regression 
of tumors, has been found effective. Dexamethasone has a longer 
half-life than has hydrocortisone (36 to 54 hours vs. 8 to 12 hours) 
and more effectively suppresses the hypothalamic-pituitary axis
13). If 
the tumors do not respond to dexamethasone, surgical intervention 
should be considered. Testis-sparing surgery is preferred for 
prepubertal tumors, with psychological and cosmetic advantages. 
However, in the case of longstanding tumors in patients with poorly 
controlled CAH, irreversible testicular damage may persist after 
surgery
10). 
Molecular analysis of CYP21A2 in our patient revealed mutations 
common in CAH of the salt-wasting type, but our patient had not 
shown any symptoms of adrenal crisis during childhood. This may 
have been because his TARTs had some features of adrenal cells 
because of the presence of CYP11B1 and CYP11B2 in tumor tissue
14). 
It is unusual to find a CAH patient of the salt-wasting type who in 
the absence of treatment, did not present with salt-wasting symptoms. 
Because TARTs may cause deterioration in semen production as 
well as testosterone secretion, semen analysis may help to evaluate 
gonadal function in adults. As poor compliance with medication 
can aggravate TARTs, patients should be regularly followed-up and 
controlled with appropriate medication, to prevent residual tumor 
regrowth. 
In conclusion, early detection of TARTs is important in preventing 
irreversible testicular damage. Patients with CAH should be regularly 
examined by digital palpation and radiological methods such as 
ultrasonography, to detect small-sized tumors. 140      HY Jin, et al. • Testicular adrenal rest tumors in untreated congenital adrenal hyperplasia
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